Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 2
2000 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

4 results
Results by year
Filters applied: . Clear all
Page 1
Altered expression of retinoblastoma (RB) protein in acute myelogenous leukemia does not result from methylation of the Rb promotor.
Kornblau SM, Qiu YH. Kornblau SM, et al. Leuk Lymphoma. 1999 Oct;35(3-4):283-8. doi: 10.3109/10428199909145731. Leuk Lymphoma. 1999. PMID: 10706451
BAX and PKCalpha modulate the prognostic impact of BCL2 expression in acute myelogenous leukemia.
Kornblau SM, Vu HT, Ruvolo P, Estrov Z, O'Brien S, Cortes J, Kantarjian H, Andreeff M, May WS. Kornblau SM, et al. Clin Cancer Res. 2000 Apr;6(4):1401-9. Clin Cancer Res. 2000. PMID: 10778970 Free article.
The prognostic impact of BCL2 protein expression in acute myelogenous leukemia varies with cytogenetics.
Kornblau SM, Thall PF, Estrov Z, Walterscheid M, Patel S, Theriault A, Keating MJ, Kantarjian H, Estey E, Andreeff M. Kornblau SM, et al. Clin Cancer Res. 1999 Jul;5(7):1758-66. Clin Cancer Res. 1999. PMID: 10430080 Free article.
Low and maximally phosphorylated levels of the retinoblastoma protein confer poor prognosis in newly diagnosed acute myelogenous leukemia: a prospective study.
Kornblau SM, Andreeff M, Hu SX, Xu HJ, Patel S, Theriault A, Koller C, Kantarjian H, Estey E, Deisseroth AB, Benedict WF. Kornblau SM, et al. Clin Cancer Res. 1998 Aug;4(8):1955-63. Clin Cancer Res. 1998. PMID: 9717825 Free article.
Feedback